Gilead Sciences (GILD.US) announced that it had struck a licensing agreement to produce the antiviral drug remdesivir in 127 countries, not including the US. The company’s will work with five generic drugmakers to produce the potential drug for coronavirus. Among them is Mylan (MYL.US), which is the world's largest producer of generic drugs.

Gilead Sciences (GILD.US) shares rose 1.96% in pre-market trading. If positive mood persists, then resistance at $86.16 per share may be tested. Source: xStation5
US OPEN: SpaceX pushes Amazon off the TOP 5 podium. Wall Street awaits Warsh's debut
SpaceX Acquires Cursor for $60 Billion. Why Musk Needed Cursor So Badly
European stocks on the rise again 🔼 EU50 near record high
SpaceX shares continue to soar 🔼 The stock is up nearly 30% since its record-breaking IPO